MétaCan
Menu
Back to cohort
Record W4404068977 · doi:10.1002/cam4.70332

Disease Characteristics and Outcomes of 493 Young Myeloma Patients Treated With Modern Therapies: A Canadian Myeloma Research Group Database Study

2024· article· en· W4404068977 on OpenAlexafffundabout
Mégane Tanguay, Jean Roy, Jiandong Su, Engin Gul, Donna Reece, Christopher P. Venner, Darrell White, Michael P. Chu, Victor H. Jimenez‐Zepada, Kevin Song, Arleigh McCurdy, Hira Mian, Michaël Sébag, Debra Bergstrom, Julie Stakiw, Tony Reiman, Rami Kotb, Muhammad Aslam, Rayan Kaedbey, Martha Louzada, Richard LeBlanc

Bibliographic record

VenueCancer Medicine · 2024
Typearticle
Languageen
FieldMedicine
TopicMultiple Myeloma Research and Treatments
Canadian institutionsJewish General HospitalMemorial University of NewfoundlandMcGill UniversityJuravinski Cancer CentreOttawa Regional Cancer FoundationSaskatchewan Cancer AgencyCancerCare ManitobaOttawa HospitalPrincess Margaret Cancer CentreVancouver General HospitalUniversity of CalgaryUniversity of British ColumbiaSaint John Regional HospitalBC Cancer AgencyDalhousie UniversityCanadian Apheresis GroupUniversity of AlbertaQueen Elizabeth II Health Sciences CentreUniversity of SaskatchewanUniversité de MontréalHôpital Maisonneuve-Rosemont
FundersUniversité de MontréalRegeneron PharmaceuticalsHamilton Health SciencesGilead SciencesSanofiCelgeneAstraZenecaHamilton Health Sciences FoundationPfizerAmgen
KeywordsMedicineMultiple myelomaInternal medicinePopulationMaintenance therapyAutologous stem-cell transplantationSurgeryLenalidomideOncologyChemotherapy

Abstract

fetched live from OpenAlex

BACKGROUND: Young patients ≤ 50 years old with multiple myeloma (MM) account for about 10% of cases and are underrepresented in the literature. METHODS: We explored disease characteristics, treatments, and outcomes following modern therapies of young MM patients using the Canadian Myeloma Research Group (CMRG) database. We included 493 patients ≤ 50 years old diagnosed with MM or plasma cell leukemia without concurrent amyloidosis or POEMS syndrome from January 1, 2010, to July 1, 2022. RESULTS: The median age was 46 years old (range: 25.6-50). Most patients fell into the R-ISS II category (72.7%), and 24.1% had high-risk cytogenetics. The majority of patients (89.9%) received a proteasome inhibitor-based first-line treatment, 92.1% received a stem cell transplant, and 65.6% had maintenance therapy post-autologous stem cell transplant (ASCT). Median follow-up from initial treatment to patients' last follow-up was 48.5 (range: 0-155) months. Median progression-free survival (PFS) was 45.0 months (95% CI: 40.2-50.0). Maintenance therapy post-ASCT improved median PFS to 52.3 months (95% CI: 43.1-68.2), compared to 23.6 months (95% CI: 20.0-34.8) without maintenance [p < 0.001]. CONCLUSION: Although the overall survival has not yet been reached in this young population, our reported median PFS of only 45 months highlights the urgent need to develop innovative treatments to induce more profound and durable responses.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.042
Threshold uncertainty score0.969

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0010.000
Bibliometrics0.0010.001
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.053
GPT teacher head0.371
Teacher spread0.319 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2024
Admission routes3
Has abstractyes

Explore more

Same venueCancer MedicineSame topicMultiple Myeloma Research and TreatmentsFrench-language works237,207